- Join over 1.2 million students every month
- Accelerate your learning by 29%
- Unlimited access for just £4.99 per month
Merck Pharmaceuticals Analysis. Merck is a healthy company to invest in with a diverse portfolio since their merger with Schering-Plough in 2007. Before investing however, there are a few things to consider.
- Essay length: 3972 words
- Submitted: 30/04/2012
This essay hasn't yet been marked by one of our teachers
You can view all our essays on Finance that have been Marked by Teachers
The first 200 words of this essay...
Merck: Leading the World in Pharmaceutical and Chemical Production
Amber Stone
MGT 531
December 1, 2011
Leslie Ann L. Dunn, MBA, JD
Merck: Leading the World in Pharmaceutical and Chemical Production
Even though Merck faces threats from generic competition, they are the world's leader in healthcare and chemical production because their pioneering inventions save lives which drives continued sales growth. As a mutual fund manager, big pharma means big business. After all, there's no doubt that medicine saves lives. Both innovative and lucrative, Chief Research Officers agree that risky pharmaceutical investments can lead to great returns. Merck is a healthy company to invest in with a diverse portfolio since their merger with Schering-Plough in 2007. Before investing however, there are a few things to consider.
Strengths
Weaknesses
* Increased late stage R&D pipeline
* Consistent output of blockbuster products
* Gardasil and Zostavax patent extension
* Balance of high and low risk products
* Expansion of innovative biotechnology and pharmacogenomics
* Market expansion through acquisitions
* Output of drugs that target niche diseases (Opposite of blockbusters)
* Patent expiration dates become public
Found what you're looking for?
- Start learning 29% faster today
- Over 150,000 essays available
- Just £4.99 a month
How can Marked by Teachers help you?
Not the one? We have 100's more
Finance (view all)
